BioNovo, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 265 613
Cost of Revenue - -
Gross Profit 265 613
Operating Expenses
Research and Development 20,528 14,642
Sales, General and Admin. 3,367 3,526
Non-Recurring Items - -
Other - -
Operating Income (23,630) (17,555)
Income From Continuing Operations
Add'l Income/Expense Items 10,029 (115)
Earnings Before Interest and Tax (13,601) (17,670)
Interest Expense 97 61
Earnings Before Tax (13,698) (17,731)
Income Tax 1 1
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (13,699) (17,732)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (13,699) (17,732)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (13,699) (17,732)